A Randomized Clinical Trial
Giancarlo Natalucci, MD1,2; Beatrice Latal, MD, MPH2; Brigitte Koller, RN1; Christoph Rüegger, MD1; Beate Sick, PhD3; Leonhard Held, PhD3; Hans Ulrich Bucher, MD1; Jean-Claude Fauchère, MD1 ; for the the Swiss EPO Neuroprotection Trial Group
Richard T. Ellison III, MD reviewing Tang H et al. Cell Stem Cell 2016 Mar 4. Garcez PP et al. Science 2016 Apr 10.
Deborah Cowley, MD reviewing Dolk H et al. Neurology 2016 Apr 6.
Jeffrey Gelfand, MD reviewing Lublin F et al. Lancet 2016 Mar 12.
Kaup A, Byers A, Falvey C, Simonsick E, Satterfield S, Ayonayon H, Smagula S, Rubin S, Yaffe K
Daniel J. Pallin, MD, MPH reviewing Laitio R et al. JAMA 2016 Mar 15.
Jaime Toro, MD reviewing Morris MC et al. JAMA 2016 Feb 2. Kröger E and Laforce R. JAMA 2016 Feb 2.
Jennifer Rose V. Molano, MD reviewing Johnson KA et al. Ann Neurol 2016 Jan.
Tau imaging may be a new biomarker in Alzheimer disease.
Robert T. Naismith, MD reviewing Sotirchos ES et al. Neurology 2015 Dec 30.
Anticoagulation Resumption After a GI Bleed Is Associated with Lower Mortality in AF
Hooman Kamel, MD reviewing Staerk L et al. BMJ 2015 Nov 16.